We also show that pridopidine, which is a dopaminergic stabilizer that has been evaluated as a treatment for Huntington’s disease [43–46], elevates IKBKAP transcription and as consequence IKAP protein levels. This evidence concerns the gene ELP1 and Huntington disease.